Cel Sci Corp
CVM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000725363
In the last 90 days, Cel Sci Corp insiders filed 1 open-market purchase and 0 sales; 40 institutions reported holding it in 13F filings for Q2 2026, worth $2.08M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Cel Sci Corp changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 39 | 40 | +1 |
| Shares | 762.7K | 2.00M | +1.23M (+161.7%) |
| Value | $2.43M | $2.08M | −$351.3K (−14.5%) |
New holders (9)
Institutions that held Cel Sci Corp at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 198,500 | $206.4K | 0.00% |
| HRT Financial LP | 51,155 | $53.0K | 0.00% |
| Jane Street Group, LLC | 36,458 | $37.9K | 0.00% |
| Raymond James Financial Inc | 16,013 | $16.7K | 0.00% |
| Virtu Financial LLC | 11,315 | $12.0K | 0.00% |
| Financial Consulate, Inc | 10,000 | $10.4K | 0.00% |
| Buck Wealth Strategies, LLC | 256 | $266 | 0.00% |
| Caitong International Asset Management Co., Ltd | 5 | $5 | 0.00% |
| Tounjian Advisory Partners, LLC | 2 | $2 | 0.00% |
Sold out (8)
Institutions that held Cel Sci Corp at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Forthright Family Wealth Advisory LLC | 16,500 | $31.5K |
| Tower Research Capital LLC (TRC) | 2,397 | $7.69K |
| Archer Investment Corp | 1,500 | $4.82K |
| Wells Fargo & Company | 766 | $2.46K |
| Advisory Services Network, LLC | 9 | $29 |
| SBI Securities Co., Ltd. | 6 | $19 |
| Frazier Financial Advisors, LLC | 3 | $10 |
| Mark Sheptoff Financial Planning, LLC | 1 | $2 |